The DOI matches its Crossref record.
The Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness
Abstract
D-lysergic acid diethylamide (LSD 25) was first prepared in 1938 by Stoll and Hofmann. It is the synthetic amide of d-lysergic acid with a secondary amine, diethylamine and belongs to the ergonovine group of ergot alkaloids all of which have lysergic acid as a base. After its ingestion in minute doses, it induces psychic states in which the subject becomes aware of repressed memories and other unconscious material in a setting of clear consciousness. This preliminary paper describes the results obtained from the use of the drug in 36 psychoneurotic patients over a period of one year. We consider that the drug will find a significant place in the treatment of the psychoneuroses and allied mental illnesses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideas
Carhart-Harris, R. L., & Friston, K. J. (2010) · Brain · doi:10.1093/brain/awq010 · Cited by 574
Psychiatry & the psychedelic drugs. Past, present & future
Rucker, J. J. H., Iliff, J., & Nutt, D. J. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.040 · Cited by 343
Implications of LSD and experimental mysticism
Pahnke, W. N., & Richards, W. A. (1966) · Journal of Religion and Health · doi:10.1007/bf01532646 · Cited by 252
Clinical applications of hallucinogens: a review
Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000084 · Cited by 201
“The first generation of clinical psychedelic research began in the mid-20th century and focused almost exclusively on LSD, mescaline, and psilocybin (e.g., Cohen, 1959; Evarts, 1957; Hollister & Hartman, 1962; Isbell, 1959; Isbell, 1959; Rinkel, 1957; Sandison et al., 1954; Stoll, 1947; Wolbach et al., 1962).”
BackgroundOrsolini, L., Papanti, G. D., De Berardis, D., Guirguis, A., Corkery, J. M., & Schifano, F. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00240 · Cited by 99
Greenway, K. T., Garel, N., Jerome, L., & Feduccia, A. A. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1772054 · Cited by 94
Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications
Kraehenmann, R. (2017) · Current Neuropharmacology · doi:10.2174/1573413713666170619092629 · Cited by 92
Lower-dose psycholytic therapy – A neglected approach
Passie, T., Guss, J., & Krähenmann, R. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1020505 · Cited by 81
Historic psychedelic drug trials and the treatment of anxiety disorders.
Weston, N. M., Gibbs, D., Bird, C. I. V., Daniel, A., Jelen, L. A., Knight, G., Goldsmith, D., Young, A. H., & Rucker, J. J. (2020) · Depression and Anxiety · doi:10.1002/da.23065 · Cited by 38
Neurotoxicity and LSD treatment: a follow-up study of 151 patients in Denmark
Larsen, J. K. (2016) · History of Psychiatry · doi:10.1177/0957154x16629902 · Cited by 29
Pharmacological Treatment of Hallucinogen Persisting Perception Disorder (HPPD): A Systematic Review
Neven, A., & Blom, J. D. (2025) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000439 · Cited by 4
Could psychedelics treat personality disorders
(2022) · Journal of Addiction Science · doi:10.17756/jas.2022-057 · Cited by 3
Metadata
- Authors
- Sandison, R. A., Spencer, A. M., & Whitelaw, J. D. A.
- Venue
- Journal of Mental Science
- Publisher
- Royal College of Psychiatrists
- Published
- 1954-04
- Volume
- 100
- Issue
- 419
- Pages
- 491-507
- ISSN
- 0368-315X (ISSN-L)
- 2514-9946
- OpenAlex
- W2075552167
- Cited by
- 196
- References
- 0
- FWCI
- 42.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.